Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zicam Maker Matrixx' Sales Plummet While Legal Costs Climb

This article was originally published in The Tan Sheet

Executive Summary

Zicam manufacturer Matrixx Initiatives' sales dropped more than 50 percent in its most recent quarter as its legal costs continue to grow

You may also be interested in...



Church & Dwight Takes Homeopathic Turn For OTC Sales Driver, Acquires Zicam Marketer Matrixx

C&D CEO Matthew Farrell says Zicam has 73% share in the US zinc-containing wellness product market. It's acquiring marketer Matrixx Initiatives at a price almost 15 times Zicam brand’s projected 2021 EBITDA.

Reformulated Zicam Nasal Swabs Return Matrixx To Top Sales Category

Matrixx Initiatives re-launches Zicam Cold Remedy Nasal Swabs with “plant-based ingredients” replacing the original product’s zinc gluconate. Consumer trust in the Zicam brand prompted the reformulation and re-launch, says CEO M’lou Walker.

Reformulated Zicam Nasal Swabs Return Matrixx To Top Sales Category

Matrixx Initiatives re-launches Zicam Cold Remedy Nasal Swabs with “plant-based ingredients” replacing the original product’s zinc gluconate. Consumer trust in the Zicam brand prompted the reformulation and re-launch, says CEO M’lou Walker.

Related Content

Topics

UsernamePublicRestriction

Register

ID005817

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel